Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance

Abstract Novelty and Impact Statement: Our findings suggest that soluble folate receptor (sFR) could be used in both the initial diagnosis and surveillance of patients with ovarian cancer. Our cohort constitutes one of the largest comparison groups for sFR analyzed so far. We have defined the backgr...

Full description

Saved in:
Bibliographic Details
Main Authors: Batoul Farran, Samet Albayrak, Judith Abrams, Michael A. Tainsky, Nancy K. Levin, Robert Morris, Larry H. Matherly, Manohar Ratnam, Ira Winer
Format: Article
Language:English
Published: Wiley 2019-03-01
Series:Cancer Medicine
Subjects:
Online Access:https://doi.org/10.1002/cam4.1944
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832576225266106368
author Batoul Farran
Samet Albayrak
Judith Abrams
Michael A. Tainsky
Nancy K. Levin
Robert Morris
Larry H. Matherly
Manohar Ratnam
Ira Winer
author_facet Batoul Farran
Samet Albayrak
Judith Abrams
Michael A. Tainsky
Nancy K. Levin
Robert Morris
Larry H. Matherly
Manohar Ratnam
Ira Winer
author_sort Batoul Farran
collection DOAJ
description Abstract Novelty and Impact Statement: Our findings suggest that soluble folate receptor (sFR) could be used in both the initial diagnosis and surveillance of patients with ovarian cancer. Our cohort constitutes one of the largest comparison groups for sFR analyzed so far. We have defined the background level of sFR using healthy volunteers. This is also the first study to prospectively follow patients in the surveillance setting to concurrently identify differential changes in tumor markers CA‐125 and sFR.
format Article
id doaj-art-b86d3a7480844c61bdfcceaf39caea1a
institution Kabale University
issn 2045-7634
language English
publishDate 2019-03-01
publisher Wiley
record_format Article
series Cancer Medicine
spelling doaj-art-b86d3a7480844c61bdfcceaf39caea1a2025-01-31T08:47:42ZengWileyCancer Medicine2045-76342019-03-018392092710.1002/cam4.1944Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillanceBatoul Farran0Samet Albayrak1Judith Abrams2Michael A. Tainsky3Nancy K. Levin4Robert Morris5Larry H. Matherly6Manohar Ratnam7Ira Winer8Department of Oncology Wayne State University and Karmanos Cancer Institute Detroit MichiganDepartment of Obstetrics and Gynecology Wayne State University Detroit MichiganDepartment of Oncology Wayne State University and Karmanos Cancer Institute Detroit MichiganDepartment of Oncology Wayne State University and Karmanos Cancer Institute and Center for Molecular Medicine and Genetics Detroit MichiganDepartment of Oncology Wayne State University and Karmanos Cancer Institute Detroit MichiganDepartment of Oncology, Division of Gynecologic Oncology Wayne State University and Karmanos Cancer Institute Detroit MichiganDepartments of Oncology and Pharmacology Wayne State University and Karmanos Cancer Institute Detroit MichiganDepartment of Oncology Wayne State University and Karmanos Cancer Institute Detroit MichiganDepartment of Oncology, Division of Gynecologic Oncology Wayne State University and Karmanos Cancer Institute Detroit MichiganAbstract Novelty and Impact Statement: Our findings suggest that soluble folate receptor (sFR) could be used in both the initial diagnosis and surveillance of patients with ovarian cancer. Our cohort constitutes one of the largest comparison groups for sFR analyzed so far. We have defined the background level of sFR using healthy volunteers. This is also the first study to prospectively follow patients in the surveillance setting to concurrently identify differential changes in tumor markers CA‐125 and sFR.https://doi.org/10.1002/cam4.1944biomarkersgynecologic oncologytranslational research
spellingShingle Batoul Farran
Samet Albayrak
Judith Abrams
Michael A. Tainsky
Nancy K. Levin
Robert Morris
Larry H. Matherly
Manohar Ratnam
Ira Winer
Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance
Cancer Medicine
biomarkers
gynecologic oncology
translational research
title Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance
title_full Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance
title_fullStr Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance
title_full_unstemmed Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance
title_short Serum folate receptor α (sFR) in ovarian cancer diagnosis and surveillance
title_sort serum folate receptor α sfr in ovarian cancer diagnosis and surveillance
topic biomarkers
gynecologic oncology
translational research
url https://doi.org/10.1002/cam4.1944
work_keys_str_mv AT batoulfarran serumfolatereceptorasfrinovariancancerdiagnosisandsurveillance
AT sametalbayrak serumfolatereceptorasfrinovariancancerdiagnosisandsurveillance
AT judithabrams serumfolatereceptorasfrinovariancancerdiagnosisandsurveillance
AT michaelatainsky serumfolatereceptorasfrinovariancancerdiagnosisandsurveillance
AT nancyklevin serumfolatereceptorasfrinovariancancerdiagnosisandsurveillance
AT robertmorris serumfolatereceptorasfrinovariancancerdiagnosisandsurveillance
AT larryhmatherly serumfolatereceptorasfrinovariancancerdiagnosisandsurveillance
AT manoharratnam serumfolatereceptorasfrinovariancancerdiagnosisandsurveillance
AT irawiner serumfolatereceptorasfrinovariancancerdiagnosisandsurveillance